Arcutis Biotherapeutics, Inc. (ARQT) › Cash & EquivalentsArcutis Biotherapeutics, Inc. (ARQT) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2019: $63.34M2020: $65.08M2021: $96.45M2022: $53.64M2023: $88.39M2024: $71.33M2025: $42.91M$42.91M2019Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$42.91M-39.9%2024$71.33M-19.3%2023$88.39M+64.8%2022$53.64M-44.4%2021$96.45M+48.2%2020$65.08M+2.8%2019$63.34M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share